We could not find any results for:
Make sure your spelling is correct or try broadening your search.
| Ticker | Name | Price | Change | Change % | Volume |
|---|---|---|---|---|---|
LIME | Neutron Holdings Inc | 25.10 | 23.46 | 1,430.49% | 1,124,737 |
CLRO | ClearOne Inc | 6.4788 | 3.26 | 101.20% | 88,542,618 |
CWD | CaliberCos Inc | 1.21 | 0.5647 | 87.51% | 338,030,451 |
MIDDV | Middleby Corporation | 139.52 | 58.51 | 72.23% | 1,541 |
DSY | Big Tree Cloud Holdings Limited | 4.44 | 1.56 | 54.17% | 22,719,528 |
SURG | SurgePays Inc | 0.578 | 0.1631 | 39.31% | 178,019,963 |
CMMB | Chemomab Therapeutics Ltd | 2.28 | 0.58 | 34.12% | 1,393,532 |
SLBT | SL Science Holding Ltd | 5.935 | 1.49 | 33.37% | 1,216,447 |
HLP | Hongil Group Inc | 0.7456 | 0.1861 | 33.26% | 49,489,515 |
USDE | StablecoinX Inc | 2.6901 | 0.6101 | 29.33% | 50,855,181 |
CCTG | CCSC Technology International Holdings Ltd | 0.9078 | 0.1998 | 28.22% | 25,888,790 |
ClearOne, Inc. (Nasdaq: CLRO) (“ClearOne”) announced today that it has entered into a definitive agreement and plan of merger (the “Agreement”) among its wholly-owned subsidiary (“MergerSub”), Vivani Medical, Inc. (Nasdaq: VANI; “Vivani”), and Cortigent, Inc. (“Cortigent”), a wholly-owned subsidiary of Vivani, pursuant to which Cortigent will become a wholly-owned subsidiary of ClearOne (the “Transaction”) upon consummation.
XIAMEN, China, July 1, 2026 /PRNewswire/ -- Hitek Global Inc. (Nasdaq: HKIT) (the "Company"), an information technology consulting and solutions provider, announced today that it will effect a reverse split (the "Reverse Split") at a ratio of 1-for-25, to be effective on July 6, 2026. Beginning with the opening of trading on July 6, 2026, the Company's Class A ordinary shares ("Class A Ordinary Shares") will begin trading on the Nasdaq Capital Market on a split-adjusted basis under the same trading symbol, "HKIT," and a new CUSIP number, G45139139.
Ouster, Inc. (Nasdaq: OUST) (“Ouster” or the “Company”), a leader in sensing and perception for Physical AI, today announced the pricing of an underwritten public offering of 3,621,876 shares of the Company’s common stock (the “Offering”). The shares of common stock are being sold at a public offering price of $55.22 per share, before underwriting discounts and commissions. All of the shares in the Offering are being sold by the Company. The gross proceeds to Ouster from the Offering are expected to be approximately $200.0 million, before deducting underwriting discounts and commissions and other offering expenses. The Company has granted ...
Company Disposes of Legacy Movano Assets; Shareholders Elect Three New Directors; Approve Conversion of Series C and Series D Preferred Stock; Chance Moreland Joins as CFOARLINGTON, Va., July 1, 2026 /PRNewswire/ -- Corvex, Inc. (Nasdaq: MOVE), an engineering-led AI computing platform specializing in GPU-accelerated infrastructure for AI workloads, today announced the results of its 2026 Annual Meeting of Stockholders, held virtually.
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Already have an account? Sign in
Don't have an account? Sign up
By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.